Sodium chloride/dextran 70

Drug Profile

Sodium chloride/dextran 70

Alternative Names: Hypertonic saline dextran; RescueFlow; Sodium chloride/dextran

Latest Information Update: 21 Dec 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nonindustrial source
  • Developer Karo Pharma AB; Medisan Pharmaceuticals AB; Nonindustrial source
  • Class Electrolytes
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Hypovolaemia

Most Recent Events

  • 07 Jun 2011 BioPhausia has been acquired by Medivir AB
  • 15 May 2007 Launched for Hypovolaemia in France (IV)
  • 15 May 2004 Launched for Hypovolaemia in Israel (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top